Literature DB >> 35307295

Applications of chemogenetics in non-human primates.

Jessica Raper1, Adriana Galvan2.   

Abstract

Due to its low invasiveness and controllability, chemogenetic approaches offer a highly attractive option to modulate neuronal activity in basic research and future clinical applications. Chemogenetics have revolutionized neuroscience research by facilitating manipulations of selective brain circuits. To date, however, the large majority of these studies have been conducted in rodent models, while the wide application of chemogenetics in nonhuman primates (NHPs) is yet to occur. Still, important progress has been achieved in the use of chemogenetics in NHP studies in the last few years. Here we review the studies that have been published using chemogenetics in NHPs and discuss the current limitations of the technique to its more widespread use in NHPs and possible ways to overcome them.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35307295      PMCID: PMC9167257          DOI: 10.1016/j.coph.2022.102204

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   4.768


  86 in total

1.  AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses.

Authors:  Skyler D Mendoza; Yasmine El-Shamayleh; Gregory D Horwitz
Journal:  J Neurophysiol       Date:  2017-02-15       Impact factor: 2.714

Review 2.  Chemogenetic tools to interrogate brain functions.

Authors:  Scott M Sternson; Bryan L Roth
Journal:  Annu Rev Neurosci       Date:  2014-06-16       Impact factor: 12.449

3.  AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction.

Authors:  Lluis Samaranch; Waldy San Sebastian; Adrian P Kells; Ernesto A Salegio; Gregory Heller; John R Bringas; Philip Pivirotto; Stephen DeArmond; John Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2013-11-21       Impact factor: 11.454

Review 4.  The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats.

Authors:  Erin J Campbell; Nathan J Marchant
Journal:  Br J Pharmacol       Date:  2018-02-26       Impact factor: 8.739

5.  Transcriptional and anatomical diversity of medium spiny neurons in the primate striatum.

Authors:  Jing He; Michael Kleyman; Jianjiao Chen; Aydin Alikaya; Kathryn M Rothenhoefer; Bilge Esin Ozturk; Morgan Wirthlin; Andreea C Bostan; Kenneth Fish; Leah C Byrne; Andreas R Pfenning; William R Stauffer
Journal:  Curr Biol       Date:  2021-11-01       Impact factor: 10.900

6.  Chemogenetic disconnection of monkey orbitofrontal and rhinal cortex reversibly disrupts reward value.

Authors:  Mark A G Eldridge; Walter Lerchner; Richard C Saunders; Hiroyuki Kaneko; Kristopher W Krausz; Frank J Gonzalez; Bin Ji; Makoto Higuchi; Takafumi Minamimoto; Barry J Richmond
Journal:  Nat Neurosci       Date:  2015-12-14       Impact factor: 24.884

7.  Level of hM4D(Gi) DREADD Expression Determines Inhibitory and Neurotoxic Effects in the Hippocampus.

Authors:  Marie-Gabrielle Goossens; Lars Emil Larsen; Marijke Vergaelen; Wytse Wadman; Chris Van den Haute; Wayra Brackx; Silke Proesmans; Jana Desloovere; Emma Christiaen; Erine Craey; Christian Vanhove; Kristl Vonck; Paul Boon; Robrecht Raedt
Journal:  eNeuro       Date:  2021-11-04

8.  An Open Resource for Non-human Primate Optogenetics.

Authors:  Sébastien Tremblay; Leah Acker; Arash Afraz; Daniel L Albaugh; Hidetoshi Amita; Ariana R Andrei; Alessandra Angelucci; Amir Aschner; Puiu F Balan; Michele A Basso; Giacomo Benvenuti; Martin O Bohlen; Michael J Caiola; Roberto Calcedo; James Cavanaugh; Yuzhi Chen; Spencer Chen; Mykyta M Chernov; Andrew M Clark; Ji Dai; Samantha R Debes; Karl Deisseroth; Robert Desimone; Valentin Dragoi; Seth W Egger; Mark A G Eldridge; Hala G El-Nahal; Francesco Fabbrini; Frederick Federer; Christopher R Fetsch; Michal G Fortuna; Robert M Friedman; Naotaka Fujii; Alexander Gail; Adriana Galvan; Supriya Ghosh; Marc Alwin Gieselmann; Roberto A Gulli; Okihide Hikosaka; Eghbal A Hosseini; Xing Hu; Janina Hüer; Ken-Ichi Inoue; Roger Janz; Mehrdad Jazayeri; Rundong Jiang; Niansheng Ju; Kohitij Kar; Carsten Klein; Adam Kohn; Misako Komatsu; Kazutaka Maeda; Julio C Martinez-Trujillo; Masayuki Matsumoto; John H R Maunsell; Diego Mendoza-Halliday; Ilya E Monosov; Ross S Muers; Lauri Nurminen; Michael Ortiz-Rios; Daniel J O'Shea; Stéphane Palfi; Christopher I Petkov; Sorin Pojoga; Rishi Rajalingham; Charu Ramakrishnan; Evan D Remington; Cambria Revsine; Anna W Roe; Philip N Sabes; Richard C Saunders; Hansjörg Scherberger; Michael C Schmid; Wolfram Schultz; Eyal Seidemann; Yann-Suhan Senova; Michael N Shadlen; David L Sheinberg; Caitlin Siu; Yoland Smith; Selina S Solomon; Marc A Sommer; John L Spudich; William R Stauffer; Masahiko Takada; Shiming Tang; Alexander Thiele; Stefan Treue; Wim Vanduffel; Rufin Vogels; Matthew P Whitmire; Thomas Wichmann; Robert H Wurtz; Haoran Xu; Azadeh Yazdan-Shahmorad; Krishna V Shenoy; James J DiCarlo; Michael L Platt
Journal:  Neuron       Date:  2020-10-19       Impact factor: 18.688

9.  Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain.

Authors:  Dominik F Aschauer; Sebastian Kreuz; Simon Rumpel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.

Authors:  Ken Y Chan; Min J Jang; Bryan B Yoo; Alon Greenbaum; Namita Ravi; Wei-Li Wu; Luis Sánchez-Guardado; Carlos Lois; Sarkis K Mazmanian; Benjamin E Deverman; Viviana Gradinaru
Journal:  Nat Neurosci       Date:  2017-06-26       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.